The University of Florida Health Blood and Marrow Transplantation Program began in 1981, and is the state’s longest established transplant program. UF Health physicians have performed more than 2,700 transplants in adults and children for diseases such as leukemia, multiple myeloma, lymphomas, neuroblastoma, myelodysplastic syndromes, testicular cancer, aplastic anemia, certain genetic disorders and immunodeficiency syndromes.
Our program is the first in Florida to receive accreditation from the Foundation for the Accreditation of Cellular Therapy, and is one of only 20 core centers that make up the National Heart, Lung and Blood Institute/National Cancer Institute Blood and Marrow Transplant Clinical Trials Network.
The BMT program and Hematologic Malignancies Service offer inpatient and outpatient care for patients in the state-of-the-art UF Health Shands Cancer Hospital, and in collaboration with the UF Health Cancer Center, uses a multidisciplinary patient care approach that optimizes patient outcomes and satisfaction. Our program is consistently awarded a Five Star rating by Professional Research Consultants, a research firm that conducts health care satisfaction surveys, which ranks us among the top 10 percent in the nation for inpatient satisfaction.
UF Health successfully and routinely performs stem cell transplantation to treat a broad variety of malignant and benign hematologic disorders, including among others:
- Acute and chronic leukemia
- Myelodysplastic syndromes
- Multiple myeloma
- Non-Hodgkin’s lymphoma and Hodgkin’s disease
- Myeloproliferative syndrome
- Severe aplastic anemia